Xavier Linker
Member of the Board of Directors at Brain Injury Canada/Lésions Cérébrale Canada | Montreal, Quebec, Canada
Xavier Linker’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Member of the Board of Directors at Brain Injury Canada/Lésions Cérébrale Canada in August 2021 - Present
Directeur, initiatives stratégiques at CQDM in September 2024 - Present
Coordonnateur, Programmes et Initiatives Majeures at Institut TransMedTech de Montréal in August 2023 - September 2024
Associate Director, Business Development at Healthy Brains, Healthy Lives in January 2021 - August 2023
Business Development Advisor, McGill University at Healthy Brains, Healthy Lives in March 2019 - January 2021
Business Development Manager at BSI software in March 2018 - March 2019
Key Account Manager, Lallemand Health Solutions at Lallemand in December 2016 - March 2018
Business Development Leader at Biospective Inc. in June 2016 - December 2016
Senior Account Manager/Product Specialist (Canada) at Charles River Laboratories in March 2012 - May 2016
Regional sales manager - France at Charles River Laboratories in January 2010 - March 2012
Account Manager at Charles River Laboratories in April 2005 - December 2009
Business Development internship at Pierre Fabre in April 2004 - September 2004
Research internship (research engineer) at Sanofi in February 2003 - August 2003
INSA Toulouse - Institut National des Sciences Appliquées de Toulouse, Master of Science / Engineer, July 2026
ESCP Business School, Executive education (6 months), July 2026
TBS Education, Master of Business, July 2026
Facilitator of biopharma innovation // Facilitateur d'innovation biopharma. CQDM is a pharma-based consortium active in biopharmaceutical research. Our mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM receives financial support from pharmaceutical companies Amgen, AstraZeneca (Alexion), GSK, Merck, Pfizer, Roche, Sanofi, Servier, Ono Pharma, Otsuka, Daiichi Sankyo as well as from Quebec’s Ministère de l'Économie, l'Innovation et de l'Énergie (MEIE). For more information: www.cqdm.org. Le CQDM est un consortium pharmaceutique actif dans la recherche biopharmaceutique. Notre mission est de soutenir et de faciliter la R&D collaborative multipartite visant à accélérer la translation ou transformation de technologies innovantes en solutions répondant à des besoins médicaux non satisfaits, tout en générant des retombées significatives pour l’économie québécoise et canadienne. Unique au monde, le modèle d'affaires du CQDM repose sur une approche collaborative où tous les intervenants partagent les coûts de la recherche biopharmaceutique et bénéficient de ses résultats. Le CQDM offre également un lieu de rencontre commun où les universités, les gouvernements et les compagnies biotechnologiques et pharmaceutiques convergent pour relever de nombreux défis médicaux complexes. Le CQDM reçoit le soutien financier des compagnies pharmaceutiques Amgen, AstraZeneca (Alexion), GSK, Merck, Pfizer, Roche, Sanofi, Servier, Ono Pharma, Otsuka, Daiichi Sankyo ainsi que du ministère de l'Économie, de l'Innovation et de l'Énergie (MEIE) du Québec. Pour plus d'informations : www.cqdm.org.
Discover more about Brain Injury Canada/Lésions Cérébrale Canada
Strategic Leader in Life Sciences, Corporate Director
Member of the Board of Directors at CQDM
(2012 – Present)
Member, SAB
At Meridius Bio Corporation, our vision is to transform and revolutionize the field of wound healing by active engagement of the immune system using our AIMER nanotechnology. This technology is at the forefront of innovation, driving advancements that transform the way wounds ...
Leader en innovation biopharmaceutique
Membre du conseil d’administration at Montréal InVivo
(Jun 2024 – Present)
Senior Director, Business Development at CQDM
Senior Director, Business Development at CQDM
(Oct 2019 – Present)
Director, Business Development - CQDM
Director, Business Development at CQDM
(Apr 2024 – Present)
Director of Business Development, Team Lead Québec at CQDM
We fund biopharmaceutical collaborative R&D that accelerates translation of leading-edge discoveries into therapeutics and diagnostics addressing unmet medical needs
What is Xavier Linker email address?
Email Xavier Linker at [email protected] and [email protected]. This email is the most updated Xavier Linker's email found in 2026.
How to contact Xavier Linker?
To contact Xavier Linker send an email to [email protected] or [email protected]. (updated on June 04, 2025)
What company does Xavier Linker work for?
Xavier Linker works for Brain Injury Canada/Lésions Cérébrale Canada.
What is Xavier Linker's role at Brain Injury Canada/Lésions Cérébrale Canada?
Xavier Linker is Member of the Board of Directors
What industry does Xavier Linker work in?
Xavier Linker works in the Biotechnology industry.
